| CYSB2400109 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-09 | | Bio-Thera Solutions Ltd | | | view |
| JXSS2200037 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-11-21 | | | | | view |
| JYSZ2200005 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | License Renew | 2022-02-09 | | | | | view |
| CYSB2300048 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2023-02-22 | | Livzon Mabpharm INC | | | view |
| JYSB2300064 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-04-14 | | | | | view |
| JYSB2200190 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products | Supplementary Application | 2022-10-10 | | | | | view |
| JYSB2200158 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2022-08-23 | | | | | view |
| CYSB2400221 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-08-21 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2300049 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2023-02-22 | | Livzon Mabpharm INC | | | view |
| CXSS2101048 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | New Drug Application | 2021-11-08 | | Bio-Thera Solutions Ltd | | | view |
| JYSB2300051 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-03-14 | | | | | view |
| JYSB2200156 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2022-08-22 | | | | | view |
| CYSB2400220 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-08-21 | | Bio-Thera Solutions Ltd | | | view |
| CXSS2300005 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-02-07 | | Hisun Biopharmaceutical Co Ltd | | | view |
| CXSS2101047 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | New Drug Application | 2021-11-08 | | Bio-Thera Solutions Ltd | | | view |
| JYSB2300050 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-03-14 | | | | | view |
| CXSS2101056 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | New Drug Application | 2021-12-22 | | Livzon Mabpharm INC | | | view |
| CYSB2400110 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-09 | | Bio-Thera Solutions Ltd | | | view |
| CXSS2300001 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-01-07 | | | | | view |
| JYSZ2200007 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | License Renew | 2022-02-09 | | | | | view |
